Kailera Therapeutics has raised an eye-watering $600 million in Series B financing to take its lead drug for weight loss into ...

Ultimately, the goal should be to achieve the life-saving benefits of AI, but without the data privacy trade-off. The NHS now ...

In the final episode of our special Frontiers Health limited series of the pharmaphorum podcast, web editor Nicole Raleigh ...

Activist investor Shah Capital has called on the board of directors at Novavax to put the company up for sale, citing a ...

The FDA has approved the Elecsys pTau181 test to assist in the initial assessment for Alzheimer's disease and other causes of ...

A year ago, Astellas was celebrating the first-in-class approval of its claudin 18.2-targeting cancer drug Vyloy for gastric ...

Boehringer Ingelheim and Click Therapeutics have revealed the data from their pivotal trial of digital therapeutic (DTx) ...

Interestingly, while only 16% of oncology researchers reported using AI in biomarker detection and assessment at the time of ...

Kelun-Biotech has picked up another first for its TROP2-targeting antibody-drug conjugate (ADC) sacituzumab tirumotecan ...

UCB's experimental medicine for rare disease thymidine kinase 2 deficiency (TK2d) has been shown to reduce the risk of death ...

Novo Nordisk has agreed to buy Akero Therapeutics and its drug candidate for metabolic dysfunction-associated steatohepatitis ...

"Antimicrobial resistance is outpacing advances in modern medicine, threatening the health of families worldwide," said WHO ...